Apexigen, Inc. (APGN) Earning

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.36
Day's range
$0.4

Apexigen, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/10/2023 Q2 2023 -$0.19 -$0.24 -0.05 N/A $0
05/15/2023 Q1 2023 N/A -$0.24 N/A N/A $0
02/22/2023 Q4 2022 $0.36 -$330.41 -330.77 N/A $0
11/14/2022 Q3 2022 N/A -$0.40 N/A N/A $0
08/18/2022 Q2 2022 N/A -$224.74 N/A N/A $0
05/20/2022 Q1 2022 N/A -$0.29 N/A N/A $0
04/07/2022 Q4 2021 N/A -$0.26 N/A N/A $0
12/08/2021 Q3 2021 N/A -$0.23 N/A N/A $0
08/16/2021 Q2 2021 N/A -$40.60 N/A N/A $0
06/04/2021 Q1 2021 N/A -$0.94 N/A N/A $0
09/29/2020 Q3 2020 N/A -$0.00 N/A N/A $0

Apexigen, Inc. Earnings: FAQ's

Apexigen, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based offlast year's report dates.

In the previous quarter, Apexigen, Inc. (:APGN) reported $0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.43.

The conference call for Apexigen, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Apexigen, Inc.'s latest earnings report can be read online.

Apexigen, Inc. (:APGN) has a recorded net income of $-31,452,000.Apexigen, Inc. has generated $-1.59 earnings per share over the last four quarters.

Apexigen, Inc. (:APGN) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED